MSN, moesin, 4478

N. diseases: 140; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE The relationship between moesin and the pathological stage of patients was analyzed, followed by further analyses on the correlations of moesin with nerve infiltration, tumor location and pain severity of patients with PC. 31424683 2020
Conventional (Clear Cell) Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE Of all ccRCC specimens, 106 (18.3%) were negative for ezrin, and 469 (81.7%) had positive ezrin expression; 16 (2.8%) were negative and 559 (97.2%) were positive for moesin, respectively. 31648868 2020
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.010 Biomarker group BEFREE These findings support the reversal of alcohol-induced insertion of Ca-permeable AMPARs and the enhancement of glutamatergic activity at vHipp to D1-MSNs as potential targets for intervention during early exposure to alcohol.<b>SIGNIFICANCE STATEMENT</b> Given the roles of the nucleus accumbens (NAc) in integrating cortical and allocortical information and in reward learning, it is vital to understand how inputs to this region are altered by drugs of abuse such as alcohol. 30692226 2019
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.010 Biomarker disease BEFREE Furthermore, results of genome-wide array analyses suggest that moesin is integral for early microglia activation in cuprizone and MS lesions. 30867127 2019
CUI: C0028754
Disease: Obesity
Obesity
0.010 Biomarker disease BEFREE These effects were driven by greater MSN excitability and conditioned approach behavior during metestrus/diestrus vs. proestrus/estrus in obesity-prone but not obesity-resistant rats, despite similar regulation of food intake and food motivation by the cycle in these groups. 31454509 2019
CUI: C0085632
Disease: Apathy
Apathy
0.010 Biomarker phenotype BEFREE Mice bearing VLS D2-MSN dysfunction can thus be regarded as an apathy model for future translational studies. 31304614 2019
CUI: C0206650
Disease: Fibroadenoma
Fibroadenoma
0.010 AlteredExpression disease BEFREE The positive rate of moesin protein expression was 47.8% (193/404) in breast cancer tissues, which was significantly higher than in fibroadenoma tissues (15.2%, 14/46). 30675256 2019
CUI: C0238462
Disease: Medullary carcinoma of thyroid
Medullary carcinoma of thyroid
0.010 Biomarker disease BEFREE Finally, a further 115 proteins were identified through the nLC-ESI-MS/MS analysis alone, with moesin, veriscan, and lumican being selected due to their potential involvement in MTC pathogenesis. 29581064 2019
Oestrogen receptor positive breast cancer
0.010 Biomarker disease BEFREE These results indicated that moesin may be a potential marker for poor prognosis in patients with ER-positive breast cancer treated with tamoxifen. 30675256 2019
CUI: C3496069
Disease: cocaine use
cocaine use
0.010 GeneticVariation disease BEFREE Here, we hypothesized an increase in the MSN marker PDE10a in subjects with cocaine use disorder ("cocaine users") compared to controls. 30240027 2019
CUI: C4733095
Disease: HER2-negative breast cancer
HER2-negative breast cancer
0.010 Biomarker disease BEFREE Furthermore, anti-survivin siRNA delivered by TS-MSN in HER2-negative breast-cancer control cells (MDA-MB-231) allowed significant down-regulation of the targeted anti-apoptotic protein of about 70%. 31352052 2019
CUI: C0004623
Disease: Bacterial Infections
Bacterial Infections
0.010 Biomarker group BEFREE Finally, absence of either SHP-1, moesin, or myosin IIA ablated the capacity of macrophages to clear bacterial infection. 29247647 2018
CUI: C0027059
Disease: Myocarditis
Myocarditis
0.010 AlteredExpression disease BEFREE The release of H<sub>2</sub>S from DATS-MSN was slow and continuous in the University of Wisconsin solution (UW), correspondingly, DATS-MSN application demonstrated superior cardioprotective effects over the control and traditional H<sub>2</sub>S donors after 6 h heart preservation and 1 h reperfusion, associated with greater allograft performance including left ventricular developed pressure (LVDP) and dP/dt <sub>max</sub>, reduced plasmic CK-MB and troponin I levels, inhibited myocardial inflammation, increased antioxidant enzyme activities, preserved mitochondria structure and function, and decreased cardiomyocyte apoptosis index. 30217578 2018
CUI: C0149637
Disease: Lip Carcinoma
Lip Carcinoma
0.010 AlteredExpression disease BEFREE There was no association between moesin expression and the clinicopathological variables, but there was a tendency for patients with lip cancer and strong moesin expression to have lower 5- and 10-year overall and disease-free survival rates. 29715096 2018
CUI: C0153340
Disease: Cancer of Lip
Cancer of Lip
0.010 AlteredExpression disease BEFREE There was no association between moesin expression and the clinicopathological variables, but there was a tendency for patients with lip cancer and strong moesin expression to have lower 5- and 10-year overall and disease-free survival rates. 29715096 2018
CUI: C0153381
Disease: Malignant neoplasm of mouth
Malignant neoplasm of mouth
0.010 Biomarker group BEFREE Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer. 29310601 2018
CUI: C0220641
Disease: Lip and Oral Cavity Carcinoma
Lip and Oral Cavity Carcinoma
0.010 Biomarker disease BEFREE Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer. 29310601 2018
Metastatic malignant neoplasm to brain
0.010 Biomarker disease BEFREE Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. 30026327 2018
CUI: C0280100
Disease: Solid Neoplasm
Solid Neoplasm
0.010 Biomarker phenotype BEFREE Our results clearly demonstrate a promising potential of CMSN-PEG for the treatment of solid tumors. 29453086 2018
CUI: C0280302
Disease: Squamous cell carcinoma of lip
Squamous cell carcinoma of lip
0.010 Biomarker disease BEFREE Our results confirm the participation of moesin in oral carcinogenesis and suggest that this protein can influence the survival rates of patients with lip squamous cell carcinoma. 29715096 2018
CUI: C0342257
Disease: Complications of Diabetes Mellitus
Complications of Diabetes Mellitus
0.010 Biomarker group BEFREE Ezrin, radixin and moesin (ERM) proteins have recently been involved in vascular dysfunction under the effect of molecular mediators of diabetes complications. 30332939 2018
CUI: C0424295
Disease: Hyperactive behavior
Hyperactive behavior
0.010 AlteredExpression phenotype BEFREE We therefore hypothesized that PAE-linked hyperactivity was due to persistently altered glutamatergic activity in DMS D1-MSNs. 29870053 2018
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.010 Biomarker disease BEFREE These downstream effectors of KLK4-7, MSN and KRT19 may represent important therapeutic targets in serous ovarian cancer. 30287916 2018
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.010 Biomarker disease BEFREE These downstream effectors of KLK4-7, MSN and KRT19 may represent important therapeutic targets in serous ovarian cancer. 30287916 2018
CUI: C1510472
Disease: Drug Dependence
Drug Dependence
0.010 Biomarker group BEFREE The nucleus accumbens (NAc) is a brain region implicated in pathological motivated behaviors such as drug addiction and is composed predominantly of two discrete populations of neurons, dopamine receptor-1- and dopamine receptor-2-expressing medium spiny neurons (D1-MSNs and D2-MSNs, respectively). 29921416 2018